FSMAX
Price
$117.72
Change
-$1.39 (-1.17%)
Updated
Aug 20 closing price
Net Assets
40.08B
TRMNX
Price
$25.52
Change
+$0.25 (+0.99%)
Updated
Aug 21 closing price
Net Assets
514.5M
Interact to see
Advertisement

FSMAX vs TRMNX

FSMAX vs TRMNX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. TRMNX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and TRMNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40.1B vs. TRMNX (514M). TRMNX pays higher dividends than FSMAX: TRMNX (0.67) vs FSMAX (0.50). FSMAX was incepted earlier than TRMNX: FSMAX (15 years) vs TRMNX (11 years). TRMNX (0.90) is less costly to investors than FSMAX (0.04). TRMNX is a more actively managed with annual turnover of: 39.30 vs. FSMAX (23.00). FSMAX has a lower initial minimum investment than TRMNX: FSMAX (0) vs TRMNX (2500). FSMAX annual gain was more profitable for investors over the last year : 23.68 vs. TRMNX (14.18). FSMAX return over 5 years is better than : 40.14 vs. TRMNX (29.65).
FSMAXTRMNXFSMAX / TRMNX
Total Expense Ratio0.040.2713%
Annual Report Gross Expense Ratio0.040.904%
Fund Existence15 years11 years-
Gain YTD16.93715.475109%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets40.1B514M7,802%
Annual Yield % from dividends0.500.6776%
Returns for 1 year23.6814.18167%
Returns for 3 years72.7467.32108%
Returns for 5 years40.1429.65135%
Returns for 10 years134.49154.9887%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IGAIX51.350.59
+1.16%
American Funds Intl Gr and Inc F-3
WAMVX4.940.05
+1.02%
Wasatch Micro Cap Value
RUSTX18.850.11
+0.59%
Russell Inv US Strategic Equity M
RTSGX5.740.02
+0.35%
Transamerica Small Cap Growth R6
HFDRX21.870.06
+0.28%
Hartford Schroders US MidCap Opps R3